This company listing is no longer active
1PR1 Stock Overview
Operates as a plant-based wellness and pharma solutions company in Israel.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Citrine Global Corp. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.015 |
52 Week High | US$0.10 |
52 Week Low | US$0.011 |
Beta | 1.27 |
11 Month Change | 25.00% |
3 Month Change | 20.00% |
1 Year Change | -46.43% |
33 Year Change | -87.33% |
5 Year Change | -96.25% |
Change since IPO | -96.88% |
Recent News & Updates
Recent updates
Shareholder Returns
1PR1 | DE Personal Products | DE Market | |
---|---|---|---|
7D | 0% | 5.8% | 4.5% |
1Y | -46.4% | 10.2% | 13.5% |
Return vs Industry: 1PR1 underperformed the German Personal Products industry which returned -4.7% over the past year.
Return vs Market: 1PR1 underperformed the German Market which returned -17.8% over the past year.
Price Volatility
1PR1 volatility | |
---|---|
1PR1 Average Weekly Movement | 10.8% |
Personal Products Industry Average Movement | 4.6% |
Market Average Movement | 5.0% |
10% most volatile stocks in DE Market | 11.6% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 1PR1's share price has been volatile over the past 3 months.
Volatility Over Time: 1PR1's weekly volatility has decreased from 24% to 11% over the past year, but is still higher than 75% of German stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2010 | 18 | Ora Soffer | www.citrine-global.com |
Citrine Global Corp. operates as a plant-based wellness and pharma solutions company. It focuses on developing plant-based products to enhance quality of life, and complementary solutions for balancing side effects caused by using medicines, cannabis, treatments, or an unbalanced lifestyle. The company was formerly known as TechCare Corp. and changed its name to Citrine Global Corp. in August 2020.
Citrine Global Corp. Fundamentals Summary
1PR1 fundamental statistics | |
---|---|
Market cap | €16.17m |
Earnings (TTM) | -€3.08m |
Revenue (TTM) | n/a |
0.0x
P/S Ratio-5.3x
P/E RatioIs 1PR1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
1PR1 income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | US$3.15m |
Earnings | -US$3.14m |
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | -0.0033 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | -93.6% |
How did 1PR1 perform over the long term?
See historical performance and comparison